| Id |
Subject |
Object |
Predicate |
Lexical cue |
| SS1_22823909_2_0 |
139-179 |
expanded |
denotes |
5-hydroxytryptamine receptor antagonists |
| SS2_22823909_2_0 |
181-190 |
abbr |
denotes |
5-HT3 RAs |
| SS1_22823909_2_1 |
274-286 |
expanded |
denotes |
chemotherapy |
| SS2_22823909_2_1 |
288-290 |
abbr |
denotes |
CT |
| SS1_22823909_2_2 |
364-391 |
expanded |
denotes |
highly emetogenic CT agents |
| SS2_22823909_2_2 |
393-396 |
abbr |
denotes |
HEC |
| SS1_22823909_3_0 |
554-574 |
expanded |
denotes |
emergency department |
| SS2_22823909_3_0 |
576-578 |
abbr |
denotes |
ED |
| SS1_22823909_5_0 |
645-658 |
expanded |
denotes |
breast cancer |
| SS2_22823909_5_0 |
660-662 |
abbr |
denotes |
BC |
| SS1_22823909_5_1 |
699-725 |
expanded |
denotes |
lung cancer on carboplatin |
| SS2_22823909_5_1 |
727-741 |
abbr |
denotes |
LC-carboplatin |
| AE1_22823909_2_0 |
SS1_22823909_2_0 |
SS2_22823909_2_0 |
abbreviatedTo |
5-hydroxytryptamine receptor antagonists,5-HT3 RAs |
| AE1_22823909_2_1 |
SS1_22823909_2_1 |
SS2_22823909_2_1 |
abbreviatedTo |
chemotherapy,CT |
| AE1_22823909_2_2 |
SS1_22823909_2_2 |
SS2_22823909_2_2 |
abbreviatedTo |
highly emetogenic CT agents,HEC |
| AE1_22823909_3_0 |
SS1_22823909_3_0 |
SS2_22823909_3_0 |
abbreviatedTo |
emergency department,ED |
| AE1_22823909_5_0 |
SS1_22823909_5_0 |
SS2_22823909_5_0 |
abbreviatedTo |
breast cancer,BC |
| AE1_22823909_5_1 |
SS1_22823909_5_1 |
SS2_22823909_5_1 |
abbreviatedTo |
lung cancer on carboplatin,LC-carboplatin |
